Case Number 6458
Request Date 10/01/2019
Completion Date 29/01/2019

 

Details of the Request

Within your Trust how many Intra-vltreat Injections / Implants have been used in the latest 4 months, if possible between September and December ’18.

If your Trust is able to identify Injections / Implants by eye conditions please split by the drug used

  1. Ranibizumab,
  2. Bevacizumab,
  3. Aflibercept,
  4. Fluocinolone and
  5. Dexamethasone
  • Lucentis (Ranibizumab) Injections
  • Avastin (Bevacizumab) Injections
  • Eylea (Aflibercept) Injections
  • Illuvieb (Fluocinolone) Implants
  • Ozudex (Dexamethasone) Implants
  • Total
  • Wet Age Related Macular Degeneration (wAMD)
  • Diabetic Macualr Oedema (DMO)
  • Retinal Vein Occlusion – Central or Branch (CRVO or BRVO)
  • Other e.g. Mcnv

 

Details of the Response

  Lucentis (Ranibizumab) Injections Avastin (Bevacizumab) Injections Eylea (Aflibercept) Injections Illuvien (Fluocinolone) Implants Ozudex (Dexamethasone) Implants
Wet Age Related Macular Degeneration (wAMD) 482 0 468 0 0
Diabetic Macular Oedema (DMO) 128 0 73 1 6
Retinal Vein Occlusion – Central or Branch (CRVO or BRVO) 37 0 55 0 2
Other: mCNV 1 0 2 0 0
Total 648 0 598 1 8